Alexander Helfand
AHN Cancer Institute-Med Onc & Infusions at Allegheny General Hospital
Office
(412) 325-5700
Fax (412) 442-2570 314 East North Avenue, Level One Pittsburgh, PA 15212Call today!
About
Alexander Helfand
Alexander Helfand, MD, is a medical oncologist and hematologist with AHN Cancer Institute, specializing in providing compassionate and empathetic oncologic and hematologic care. He diagnoses and treats blood-related illness and cancer. Dr. Helfand went to medical school at Sackler School of Medicine, New York State/American Program, in Tel Aviv, Israel. Upon completion of medical school, he did his residency at Weill Cornell Medicine: New York Presbyterian – Brooklyn Methodist Hospital in Brooklyn, New York and his fellowship in hematology/oncology at Allegheny General Hospital in Pittsburgh, Pennsylvania. Dr. Helfand is certified by the American Board of Internal Medicine and is affiliated with the American Society of Hematology and the American Society of Clinical Oncology. He speaks Spanish and Hebrew and sees patients ages 18 and older.
Primary Specialty
Hematologist
Practice
AHN Cancer Institute-Med Onc & Infusions at Allegheny General Hospital
Gender
Male
Education
Tel Aviv University Sackler School of Medicine
Training
New York Presbyterian Brooklyn Methodist Hospital, New York Presbyterian Brooklyn Methodist Hospital, AGHWPH Medical Education Consortium Internships Residencies Fellowships
Certification
American Board of Internal Medicine-Medical Oncology, American Board of Internal Medicine-Hematology
Not Accepting New Patients
Degrees
Medical Doctor
Admitting Hospitals
Allegheny General Hospital, Saint Vincent Hospital, West Penn Hospital, Jefferson Hospital, Wexford Hospital
Office Name
AHN Cancer Institute-Med Onc & Infusions at Allegheny General Hospital
Languages
English
Business Hours
Monday:8:00 AM - 4:00 PM
Tuesday:8:00 AM - 4:00 PM
Wednesday:8:00 AM - 4:00 PM
Thursday:8:00 AM - 4:00 PM
Friday:8:00 AM - 4:00 PM
Saturday:Closed
Sunday:Closed
Services
transitional cell carcinoma, cancer clinical trials, active surveillance for kidney cancer, kidney cancer clinical trials, bladder cancer immunotherapy, malignant neoplasm of ureter, prostate cancer clinical trials, bladder cancer clinical trials, non-clear cell kidney cancer, testicular cancer, urethral cancer, human papillomavirus (hpv) related penile cancer, penile cancer chemotherapy, penile cancer, clear cell renal cancer, testicular tumor, hereditary kidney cancer, testicular cancer chemotherapy, genitourinary cancers, prostate cancer, bladder cancer, scrotal tumor, kidney cancer, adjuvant chemotherapy, chemotherapy iv infusion, multi-cancer early detection blood test, advanced malignancies, systemic therapy, intravesical chemotherapy, personal history of chemotherapy, hyperthermic intraperitoneal chemotherapy (hipec), prostate cancer chemotherapy, bladder cancer chemotherapy, hormone based chemotherapy, intravesical therapy, carcinoma of unknown primary, targeted molecular therapy, intrathecal chemotherapy, maintenance chemotherapy, consolidation chemotherapy, induction chemotherapy, urachal tumor, clinical trials, intraarterial chemotherapy of tumors, cancer immunotherapy, abdominal chemotherapy, abdominal cancer, intraperitoneal hyperthermic chemoperfusion, cancer pain, cancer genomics, cancer during pregnancy, biological targeted therapy, cancer chemotherapy, cancer
Additional Services
Oncologist
Consumer Feedback
Add a Review
There are no recent reviews. Be the first!